A steep price difference between what a compounding pharmacy charged TRICARE and its cash-paying customers proved sufficient for federal prosecutors to negotiate a $1.2 million settlement—in what one health-care attorney called a novel civil prosecution strategy.
The now-defunct Florida pharmacy, RS Compounding LLC, and its owner Renier Gobea agreed to pay $1.2 million to settle allegations originally brought in a 2013 whistleblower lawsuit. The federal government intervened on some of the allegations in 2017.
The case shows “the government is willing to bring aggressive enforcement action just based on a price differential,” said Ryan Stumphauzer, a white-collar crime attorney ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.